Live tape
Top 8, mentions 7d14,333GOOGL2,869 mentions▲ +0.04NVDA2,215 mentions▲ +0.05AMD1,940 mentions▲ +0.08QQQ1,751 mentions▲ +0.05AAPL1,729 mentions▲ +0.05SPY1,560 mentions▲ +0.06TSLA1,164 mentions▲ +0.06SPCX1,105 mentions▲ +0.05

Equity · Healthcare

RLAY

NASDAQ

Relay Therapeutics (RLAY)

18.61 USD +9.60% vs prior close Nov 6, 2026
Relay Therapeutics, Inc. price graph
40 sessions
22 16 10 Aug 6 Nov

The line runs 20 USD on 10 August through 18.61 USD on 6 November, on a scale from 16 to 22. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Market cap
4.1B USD
Revenue, year to Dec 2025
15.4M USD
EPS, diluted, year to Dec 2025
−1.61 USD
52-week range
6 USD – 21 USD
Avg volume
167.3K
Mentions, 30 days
1

as of Nov 6, 2026

Have Relay Therapeutics (RLAY) insiders bought or sold shares recently?

In the 90 days to 9 Nov 2026, Relay Therapeutics insiders reported 12 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 28 Oct 2025, show no open-market purchase.

Form 4, 90 days to 9 Nov 2026, newest reported trade 28 Oct 2026

Buys 0Sells 12Net sold $120.52MOther filings 0

Have Relay Therapeutics (RLAY) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
28 Oct 2026Bergstrom Donald APresident, R&DSell2,25242K USD
28 Oct 2026Catinazzo ThomasChief Financial OfficerSell1,46927K USD
28 Oct 2026Rahmer PeterSee remarksSell75314K USD
07 Oct 2026Patel SanjivPresident and CEOSell48,199872K USD
06 Oct 2026Catinazzo ThomasChief Financial OfficerSell17,717329K USD
08 Sep 2026Bergstrom Donald APresident, R&DSell8,530162K USD
08 Sep 2026Catinazzo ThomasChief Financial OfficerSell17,717336K USD
08 Sep 2026Patel SanjivPresident and CEOSell48,199913K USD
26 Aug 2026Rahmer PeterSee remarksSell4,50890K USD
25 Aug 2026SVF Pauling (Cayman) Ltd10% OwnerSell6,000,000116.4M USD
17 Aug 2026Patel SanjivPresident and CEOSell48,199980K USD
14 Aug 2026Catinazzo ThomasChief Financial OfficerSell17,717350K USD
Sold12 open-market sales6,215,260$120.52M

Which funds hold Relay Therapeutics (RLAY)?

10 of the 45 institutional funds we track reported a Relay Therapeutics position for the quarter ended 30 Jun 2026 — a combined 122.7M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Relay Therapeutics (RLAY)?
FundPositionSharesValueShares q/q
Baker Bros. AdvisorsAdded2,826,78352.9M USD+143.7%
AQR Capital ManagementHeld (±25%)1,279,47323.9M USD−0.8%
Two Sigma InvestmentsTrimmed700,92113.1M USD−48.8%
Millennium ManagementAdded591,67511.1M USD+70.2%
Citadel AdvisorsAdded473,6828.9M USD+168.7%
Duquesne Family OfficeNew position349,0006.5M USD
Renaissance TechnologiesTrimmed192,3993.6M USD−71.4%
Balyasny Asset ManagementTrimmed112,9892.1M USD−96.3%
Marshall WaceTrimmed17,843334K USD−98.1%
Man GroupTrimmed11,618217K USD−89.7%

Have members of Congress traded Relay Therapeutics (RLAY)?

The most recent congressional trade disclosed in Relay Therapeutics is a sale by Daniel S. Goldman (house, NY), dated 12 Jul 2023.

STOCK Act disclosures

Have members of Congress traded Relay Therapeutics (RLAY)?
TradedMemberTypeAmountFiled after
12 Jul 2023Daniel S. Goldmanhouse · Democrat–NYSale1K USD–15K USD32 days

What has been filed or recorded for Relay Therapeutics (RLAY)?

The filings we hold for Relay Therapeutics, newest first: 7 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Relay Therapeutics (RLAY)?
And
13 Oct 2026Fails to deliverShares failed to deliver440,875 shares7.9M USD notional · 0.201% of shares out
09 Oct 2026Fails to deliverShares failed to deliver20,524 shares357K USD notional · 0.009% of shares out
07 Oct 2026Fails to deliverShares failed to deliver26,636 shares499K USD notional · 0.012% of shares out
06 Oct 2026Fails to deliverShares failed to deliver12,859 shares249K USD notional · 0.006% of shares out
05 Oct 2026Fails to deliverShares failed to deliver321,236 shares6.1M USD notional · 0.147% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.37 USDRevenue $3M
30 Sep 2026FinancialsTotal assets901.7M USDat period end
30 Sep 2026FinancialsTotal equity819.0M USDat period end
25 Sep 2026Fails to deliverShares failed to deliver253 shares4K USD notional · <0.001% of shares out
24 Sep 2026Fails to deliverShares failed to deliver984 shares18K USD notional · <0.001% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.41 USDRevenue $0M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.41 USDRevenue $3M
31 Dec 2025Annual reportFY 2025 reportedEPS −1.61 USDRevenue $15M
31 Dec 2025FinancialsRevenue15.4M USDfiscal year
31 Dec 2025FinancialsNet income−276.5M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−1.61 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.43 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.41 USDRevenue $1M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.46 USDRevenue $8M
31 Dec 2024Annual reportFY 2024 reportedEPS −2.36 USDRevenue $10M

What is Reddit saying about Relay Therapeutics (RLAY)?

Reddit mentioned RLAY 1 times in the 30 days to 8 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 8 November 2026.

30-day window, Method

Mentions, 30 days 1Communities 1

How do Reddit mentions of Relay Therapeutics (RLAY) compare with its price?

Share ↗
Post on X Share on Reddit Share on LinkedIn
1 mentions

Where Relay Therapeutics (RLAY) is discussed

30 days

Where Relay Therapeutics (RLAY) is discussed
CommunityShareMentionsNet sentiment
r/wallstreetbets100%1+0.15

Relay Therapeutics (RLAY): frequently asked questions

From live data
18.61

What did Relay Therapeutics shares close at?

Relay Therapeutics closed at 18.61 USD on 6 Nov 2026, up 9.60% on the close before. That is the end-of-day price from Finazon, not a live quote.

4.1B

What is Relay Therapeutics’ market cap?

Relay Therapeutics is worth 4.1B USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.

15.4M

What is Relay Therapeutics’ revenue?

Relay Therapeutics reported revenue of 15.4M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

12 sales

Have Relay Therapeutics insiders bought or sold shares recently?

In the 90 days to 9 Nov 2026, Relay Therapeutics insiders reported 12 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 28 Oct 2025, show no open-market purchase. See Insiders

10 of 45

Which funds own Relay Therapeutics?

10 of the 45 funds we track reported a Relay Therapeutics position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Baker Bros. Advisors, AQR Capital Management and Two Sigma Investments. See Funds

1 trade

Have members of Congress traded Relay Therapeutics?

Yes. 1 trade in Relay Therapeutics appears in the congressional disclosures we hold: a sale by Daniel S. Goldman (House, NY) dated 12 Jul 2023, filed 13 Aug 2023. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

−0.37

When did Relay Therapeutics last report earnings?

Relay Therapeutics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.37 USD; no next date is announced in SEC filings yet. See Filings

0 mentions

What is Reddit saying about Relay Therapeutics?

Relay Therapeutics was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SECSEC fails-to-deliver (CNS) data
  8. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  9. SEC EDGARreported earnings figures and scheduled report dates
  10. SEC EDGARValuation computed from SEC EDGAR filings